Int J Stem Cells.  2015 Nov;8(2):115-120. 10.15283/ijsc.2015.8.2.115.

A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem Cells

• Gholizadeh-Ghalehaziz S
• Farahzadi
• Fathi E
• Pashaiasl

• KMID: 2380805
• DOI: http://doi.org/10.15283/ijsc.2015.8.2.115

Abstract

Amniotic fluid represents rich sources of stem cells that can be used in treatments for a wide range of diseases. Amniotic fluid- stem cells have properties intermediate between embryonic and adult mesenchymal stem cells which make them particularly attractive for cellular regeneration and tissue engineering. Furthermore, scientists are interested in these cells because they come from the amniotic fluid that is routinely discarded after birth. In this review we give a brief introduction of amniotic fluid followed by a description of the cells present within this fluid and aim to summarize the all existing isolation methods, culturing, characterization and application of these cells. Finally, we elaborate on the differentiation and potential for these cells to promote regeneration of various tissue defects, including fetal tissue, the nervous system, heart, lungs, kidneys, bones, and cartilage in the form of table.

Keyword

Amniotic fluid; Amniotic fluid- stem cells; Isolation; Differentiation; Tissue engineering

MeSH Terms

Adult
Amniotic Fluid*
Cartilage
Female
Fetus
Heart
Humans
Kidney
Lung
Mesenchymal Stromal Cells
Nervous System
Parturition
Regeneration
Stem Cells*
Tissue Engineering

Figure

• 

  Fig. 1 Diagram for AFSCs characterization.

Reference

References

1. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005; 25:341–348. DOI: 10.1038/sj.jp.7211290. PMID: 15861199.

2. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25:100–106. DOI: 10.1038/nbt1274. PMID: 17206138.

3. Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 2008; 86:85–99. DOI: 10.1016/S0091-679X(08)00005-8. PMID: 18442645.

4. Roubelakis MG, Trohatou O, Anagnou NP. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int. 2012; 2012:107836. DOI: 10.1155/2012/107836. PMID: 22701492. PMCID: 3372280.

5. Eslaminejad MB, Jahangir S. Amniotic fluid stem cells and their application in cell-based tissue regeneration. Int J Fertil Steril. 2012; 6:147–156.

6. Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online. 2009; 18(Suppl 1):17–27. DOI: 10.1016/S1472-6483(10)60111-3. PMID: 19281660.

7. Ghionzoli M, Cananzi M, Zani A, Rossi CA, Leon FF, Pierro A, Eaton S, De Coppi P. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. 2010; 26:79–84. DOI: 10.1007/s00383-009-2504-x.

8. Steigman SA, Fauza DO. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr Protoc Stem Cell Biol. 2007; Chapter 1(Unit 1E.2):DOI: 10.1002/9780470151808.sc01e02s1.

9. In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004; 22:1338–1345. DOI: 10.1634/stemcells.2004-0058.

10. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, Bonhomme D, Ezine S, Frydman R, Cavazzana-Calvo M, André-Schmutz I. Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity. Blood. 2009; 113:3953–3960. DOI: 10.1182/blood-2008-10-182105. PMID: 19221036.

11. Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, Zund G, Hoerstrup SP. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation. 2007; 116(11 Suppl):I64–I70. DOI: 10.1161/CIRCULATIONAHA.106.681494. PMID: 17846327.

12. Cananzi M, De Coppi P. CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis. 2012; 8:77–88. DOI: 10.4161/org.22426. PMID: 23037870. PMCID: 3527320.

13. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004; 19:1450–1456. DOI: 10.1093/humrep/deh279. PMID: 15105397.

14. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A, Anagnou NP. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 2007; 16:931–952. DOI: 10.1089/scd.2007.0036. PMID: 18047393.

15. Roubelakis MG, Bitsika V, Zagoura D, Trohatou O, Pappa KI, Makridakis M, Antsaklis A, Vlahou A, Anagnou NP. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med. 2011; 15:1896–1913. DOI: 10.1111/j.1582-4934.2010.01180.x.

16. Hauser PV, De Fazio R, Bruno S, Sdei S, Grange C, Bussolati B, Benedetto C, Camussi G. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol. 2010; 177:2011–2021. DOI: 10.2353/ajpath.2010.091245. PMID: 20724594. PMCID: 2947295.

17. Donaldson AE, Cai J, Yang M, Iacovitti L. Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo. Stem Cells Dev. 2009; 18:1003–1012. DOI: 10.1089/scd.2008.0300.

18. McLaughlin D, Tsirimonaki E, Vallianatos G, Sakellaridis N, Chatzistamatiou T, Stavropoulos-Gioka C, Tsezou A, Messinis I, Mangoura D. Stable expression of a neuronal dopaminergic progenitor phenotype in cell lines derived from human amniotic fluid cells. J Neurosci Res. 2006; 83:1190–1200. DOI: 10.1002/jnr.20828. PMID: 16555279.

19. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, Habibian R, Warburton D, Atala A, De Filippo RE. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007; 40:936–948. DOI: 10.1111/j.1365-2184.2007.00478.x. PMID: 18021180.

20. Klemmt PA, Vafaizadeh V, Groner B. The potential of amniotic fluid stem cells for cellular therapy and tissue engineering. Expert Opin Biol Ther. 2011; 11:1297–1314. DOI: 10.1517/14712598.2011.587800. PMID: 21623704.

21. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, Shiri L, Lemley KV, Rosol M, Wu S, Atala A, Warburton D, De Filippo RE. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One. 2010; 5:e9357. DOI: 10.1371/journal.pone.0009357. PMID: 20195358. PMCID: 2827539.

22. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM. Lack of telomerase activity in human mesenchymal stem cells. Leukemia. 2003; 17:1146–1149. DOI: 10.1038/sj.leu.2402962. PMID: 12764382.

23. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G, Hengstschläger M. Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med. 2005; 16:987–992. PMID: 16273276.

24. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG, You J. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007; 40:75–90. DOI: 10.1111/j.1365-2184.2007.00414.x. PMID: 17227297.

25. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, Kim CJ, Erez O, Edwin S, Relman DA. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One. 2008; 3:e3056. DOI: 10.1371/journal.pone.0003056. PMID: 18725970. PMCID: 2516597.

26. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschläger M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod. 2003; 18:1489–1493. DOI: 10.1093/humrep/deg279. PMID: 12832377.

27. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001; 36:1662–1665. DOI: 10.1053/jpsu.2001.27945. PMID: 11685697.

28. Kunisaki SM, Jennings RW, Fauza DO. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev. 2006; 15:245–253. DOI: 10.1089/scd.2006.15.245. PMID: 16646670.

29. De Rosa A, Tirino V, Paino F, Tartaglione A, Mitsiadis T, Feki A, d’Aquino R, Laino L, Colacurci N, Papaccio G. Amniotic fluid-derived mesenchymal stem cells lead to bone differentiation when cocultured with dental pulp stem cells. Tissue Eng Part A. 2011; 17:645–653. DOI: 10.1089/ten.tea.2010.0340.

30. Maraldi T, Riccio M, Resca E, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, Motta A, Migliaresi C, Marzona L, De Pol A. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Eng Part A. 2011; 17:2833–2843. DOI: 10.1089/ten.tea.2011.0062. PMID: 21864161.

31. Peister A, Woodruff MA, Prince JJ, Gray DP, Hutmacher DW, Guldberg RE. Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res. 2011; 7:17–27. DOI: 10.1016/j.scr.2011.03.001. PMID: 21531647. PMCID: 3137122.

32. Cipriani S, Bonini D, Marchina E, Balgkouranidou I, Caimi L, Grassi Zucconi G, Barlati S. Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain. Cell Biol Int. 2007; 31:845–850. DOI: 10.1016/j.cellbi.2007.01.037. PMID: 17379545.

33. Pan HC, Cheng FC, Chen CJ, Lai SZ, Lee CW, Yang DY, Chang MH, Ho SP. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. J Clin Neurosci. 2007; 14:1089–1098. DOI: 10.1016/j.jocn.2006.08.008. PMID: 17954375.

34. Cheng FC, Tai MH, Sheu ML, Chen CJ, Yang DY, Su HL, Ho SP, Lai SZ, Pan HC. Enhancement of regeneration with glia cell line-derived neurotrophic factor-transduced human amniotic fluid mesenchymal stem cells after sciatic nerve crush injury. J Neurosurg. 2010; 112:868–879. DOI: 10.3171/2009.8.JNS09850.

35. Pan HC, Chen CJ, Cheng FC, Ho SP, Liu MJ, Hwang SM, Chang MH, Wang YC. Combination of G-CSF administration and human amniotic fluid mesenchymal stem cell transplantation promotes peripheral nerve regeneration. Neurochem Res. 2009; 34:518–527. DOI: 10.1007/s11064-008-9815-5.

36. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, Turcatel G, De Langhe SP, Driscoll B, Bellusci S, Minoo P, Atala A, De Filippo RE, Warburton D. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008; 26:2902–2911. DOI: 10.1634/stemcells.2008-0090. PMID: 18719226. PMCID: 3174105.

37. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, Herzog E, Niklason LE. Tissue-engineered lungs for in vivo implantation. Science. 2010; 329:538–541. DOI: 10.1126/science.1189345. PMID: 20576850. PMCID: 3640463.

38. Yeh YC, Wei HJ, Lee WY, Yu CL, Chang Y, Hsu LW, Chung MF, Tsai MS, Hwang SM, Sung HW. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A. 2010; 16:1925–1936. DOI: 10.1089/ten.tea.2009.0728. PMID: 20067384.

39. Yeh YC, Lee WY, Yu CL, Hwang SM, Chung MF, Hsu LW, Chang Y, Lin WW, Tsai MS, Wei HJ, Sung HW. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials. 2010; 31:6444–6453. DOI: 10.1016/j.biomaterials.2010.04.069. PMID: 20621766.